Warren, R. B., K. Reich, E. L. Simpson, R. Langley, A. Costanzo, H. Saeki, P. Almgren, E. Vacko, M. Gooderham, M. Deleuran, J. Francisco Silvestre, S. Weidinger, and A. Blauvelt. “3 Years of Tralokinumab Treatment Provides Long-Term Disease Control As Demonstrated by Clinically Meaningful Outcomes in Moderate-to-Severe Atopic Dermatitis”. SKIN The Journal of Cutaneous Medicine, vol. 6, no. 6, Nov. 2022, p. s78, doi:10.25251/skin.6.supp.78.